Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
21.43
+0.12 (0.56%)
At close: Mar 10, 2026, 4:00 PM EDT
21.39
-0.04 (-0.19%)
After-hours: Mar 10, 2026, 7:28 PM EDT
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $3.4 billion as of March 10, 2026. Its market cap has increased by 13.91% in one year.
Market Cap
3.40B
Enterprise Value
2.47B
1-Year Change
13.91%
Ranking
Category
Stock Price
$21.43
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $3.40B, an increase of 80.09%. That is a compound annual growth rate of 7.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 3.38B | 39.57% |
| Dec 31, 2025 | 2.42B | -17.45% |
| Dec 31, 2024 | 2.93B | -1.10% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.42% |
| Dec 31, 2019 | 1.67B | -14.73% |
| Dec 31, 2018 | 1.96B | 42.57% |
| Dec 29, 2017 | 1.38B | -27.09% |
| Dec 8, 2017 | 1.89B | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xenon Pharmaceuticals | 3.49B |
| NewAmsterdam Pharma Company | 3.43B |
| Alumis | 3.35B |
| Spyre Therapeutics | 3.15B |
| Tarsus Pharmaceuticals | 3.12B |
| Edgewise Therapeutics | 2.98B |
| Arcutis Biotherapeutics | 2.98B |
| Catalyst Pharmaceuticals | 2.96B |